← Back to headlines
Latvian Data Aids Evaluation of Multi-Drug Resistant Tuberculosis Treatment Success
A new international study published in 'The Lancet Regional Health' utilized Latvian data, showing that up to 76.9% of patients treated for multi-drug resistant or rifampicin-resistant tuberculosis in Latvia lived without disease recurrence during long-term observation.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
